Knowledge of actions of inhaled corticosteroids in patients who did not persist drug treatment early

被引:0
作者
Tanja T. Menckeberg
Jacqueline G. Hugtenburg
Jan Willem Lammers
Jan A. M. Raaijmakers
Marcel L. Bouvy
机构
[1] Utrecht University,Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences
[2] VU University Medical Center,Department of Clinical Pharmacology and Pharmacy
[3] Utrecht University,Department of Pulmonary Diseases, Utrecht Medical Centre
[4] SIR Institute for Pharmacy Practice and Policy,undefined
来源
International Journal of Clinical Pharmacy | 2012年 / 34卷
关键词
Asthma; Community pharmacy; Discontinuing treatment; Disease control; Inhaled corticosteroids; Knowledge of drugs; Netherlands;
D O I
暂无
中图分类号
学科分类号
摘要
Objective To evaluate, among new users of inhaled corticosteroids that did not persist treatment, knowledge of inhaled corticosteroids' actions and whether they were instructed on the use of their inhaler. Setting Fifteen community pharmacies in The Netherlands. Methods Patients were interviewed by telephone. Their general practitioners provided diagnostic information and automated dispensing records were retrieved. Main outcome measures Knowledge of patients about the actions of inhaled corticosteroids. Results 230 (80.1%) of 287 patients were willing to participate. The majority (79.1%) of 230 patients was not aware of the anti-inflammatory actions of inhaled corticosteroids. Most patients were instructed on the use of their inhaler, predominantly by their physician (53%) or pharmacy (35.2%). Conclusions Although most patients reported inhaler instruction by at least one health care provider, the majority was unaware of inhaled corticosteroids' actions. Physicians and pharmacists should reconsider the instructions they provide especially to patients who should continuously use inhaled corticosteroids.
引用
收藏
页码:277 / 281
页数:4
相关论文
共 94 条
[1]  
Bateman ED(2008)Global strategy for asthma management and prevention: GINA executive summary Eur Respir J 31 143-178
[2]  
Hurd SS(2003)The use of inhaled corticosteroids in the United Kingdom and the Netherlands Respir Med 97 578-585
[3]  
Barnes PJ(2000)Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique Chest 117 542-550
[4]  
Bousquet J(1995)Long-term metered-dose inhaler adherence in a clinical trial. The lung health study research group Am J Respir Crit Care Med 152 580-588
[5]  
Drazen JM(1993)Compliance with pulmonary medication in general practice Eur Respir J 6 886-890
[6]  
FitzGerald M(2004)Persistence with inhaled corticosteroid therapy in daily practice Respir Med 98 752-759
[7]  
Gibson P(2004)Patients’ problems with new medication for chronic conditions Qual Saf Health Care. 13 172-175
[8]  
Ohta K(2003)Evaluating medication effects outside of clinical trials: new-user designs Am J Epidemiol 158 915-920
[9]  
O’Byrne P(2004)Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys J Allergy Clin Immunol 114 40-47
[10]  
Pedersen SE(2000)Clinical management of asthma in 1999: the asthma insights and reality in Europe (AIRE) study Eur Respir J 16 802-807